Yifeng Pharmacy Chain Co., Ltd. (603939.SS)
CNY 25.67
(-0.62%)
CNY 25.67
(-0.62%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 22.58 Billion | 19.88 Billion | 15.32 Billion | 13.14 Billion | 10.27 Billion | 6.91 Billion |
| Cost of Revenue | 13.95 Billion | 12.02 Billion | 9.14 Billion | 8.15 Billion | 6.26 Billion | 4.16 Billion |
| Gross Profit | 8.63 Billion | 7.86 Billion | 6.18 Billion | 4.99 Billion | 4 Billion | 2.74 Billion |
| Operating Expenses | 6.5 Billion | 5.83 Billion | 4.72 Billion | 3.78 Billion | 3.14 Billion | 2.2 Billion |
| Selling, General and Administrative Expenses | 6.45 Billion | 5.01 Billion | 4.14 Billion | 3.32 Billion | 2.74 Billion | 1.92 Billion |
| Research and Development Expenses | 33.54 Million | 25.3 Million | 15.64 Million | 8.31 Million | 5.37 Million | 3.23 Million |
| Other Expenses | 15.24 Million | 797.72 Million | 567.46 Million | 450.33 Million | 394.67 Million | 2.94 Million |
| Cost and Expenses | 20.53 Billion | 17.85 Billion | 13.86 Billion | 11.93 Billion | 9.41 Billion | 6.36 Billion |
| Operating Income | 2.05 Billion | 1.88 Billion | 1.33 Billion | 1.17 Billion | 815.46 Million | 578.32 Million |
| Interest Expense | 160.52 Million | 165.2 Million | 168.98 Million | 78.53 Million | 45.79 Million | 9.71 Million |
| Income Tax Expense | 456.66 Million | 450.29 Million | 347.15 Million | 297.06 Million | 205.41 Million | 139.69 Million |
| Earnings before Tax | 2.03 Billion | 1.87 Billion | 1.33 Billion | 1.16 Billion | 814.29 Million | 581.26 Million |
| Net Income | 1.41 Billion | 1.26 Billion | 887.88 Million | 743.52 Million | 543.75 Million | 416.41 Million |
| Earnings Per Share Basic | 1.40 | 1.26 | 0.89 | 0.77 | 0.57 | 0.45 |
| Earnings Per Share Diluted | 1.17 | 1.26 | 0.89 | 0.77 | 0.57 | 0.45 |
| Weighted Average Shares Outstanding | 1 Billion | 1 Billion | 994.43 Million | 967.36 Million | 959.86 Million | 927.42 Million |
| Weighted Average Shares Outstanding (Diluted) | 1.2 Billion | 1 Billion | 1 Billion | 967.36 Million | 960.8 Million | 927.46 Million |
| Gross Margin | 0.38 | 0.40 | 0.40 | 0.38 | 0.39 | 0.40 |
| EBIT Margin | 0.18 | 0.18 | 0.18 | 0.11 | 0.09 | 0.10 |
| Profit Margin | 0.06 | 0.06 | 0.06 | 0.06 | 0.05 | 0.06 |
| EBITDA | 4.04 Billion | 3.64 Billion | 2.69 Billion | 2.14 Billion | 954.81 Million | 661.28 Million |
| Earnings Before Tax Margin | 0.09 | 0.09 | 0.09 | 0.09 | 0.08 | 0.08 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 5.43 Billion | 5.76 Billion | 5.94 Billion | 22.49 Billion | 6.66 Billion | 5.18 Billion |
| Cost of Revenue | 3.21 Billion | 3.54 Billion | 3.62 Billion | 14.37 Billion | 4.46 Billion | 3.17 Billion |
| Gross Profit | 2.22 Billion | 2.22 Billion | 2.32 Billion | 8.11 Billion | 2.2 Billion | 2 Billion |
| Operating Expenses | 1.77 Billion | 1.69 Billion | 1.73 Billion | 6.1 Billion | 1.65 Billion | 1.53 Billion |
| Selling, General and Administrative Expenses | 1.74 Billion | 1.66 Billion | 1.7 Billion | - | 1.61 Billion | 1.89 Billion |
| Research and Development Expenses | 8.31 Million | 2.96 Million | 9.77 Million | - | 14 Million | 5.39 Million |
| Other Expenses | -29.27 Million | -19.49 Million | -19.3 Million | -43.43 Million | -24.11 Million | 17.68 Thousand |
| Cost and Expenses | 4.98 Billion | 5.23 Billion | 5.35 Billion | 20.48 Billion | 6.11 Billion | 4.71 Billion |
| Operating Income | 448.14 Million | 531.07 Million | 588.19 Million | 2 Billion | 554.34 Million | 436.08 Million |
| Interest Expense | 56.85 Million | 58.37 Million | 44.35 Million | 160.52 Million | 38.19 Million | 42.43 Million |
| Income Tax Expense | 110.14 Million | 124.13 Million | 147.28 Million | 456.66 Million | 117.12 Million | 106.69 Million |
| Earnings before Tax | 448.49 Million | 538.25 Million | 593.23 Million | 2.03 Billion | 569.47 Million | 436.1 Million |
| Net Income | 312.78 Million | 390.96 Million | 406.75 Million | 1.41 Billion | 412.8 Million | 294.03 Million |
| Earnings Per Share Basic | 0.26 | 0.32 | 0.40 | - | 0.41 | 0.29 |
| Earnings Per Share Diluted | 0.26 | 0.32 | 0.40 | - | 0.41 | 0.29 |
| Weighted Average Shares Outstanding | 1.2 Billion | 1.21 Billion | 1 Billion | 1 Billion | 1 Billion | 1 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.2 Billion | 1.21 Billion | 1 Billion | 1 Billion | 1 Billion | 1 Billion |
| Gross Margin | 0.41 | 0.39 | 0.39 | 0.36 | 0.33 | 0.39 |
| EBIT Margin | 0.09 | 0.18 | 0.11 | - | 0.16 | 0.10 |
| Profit Margin | 0.06 | 0.07 | 0.07 | 0.06 | 0.06 | 0.06 |
| EBITDA | 505.34 Million | 1.04 Billion | 647.01 Million | - | 1.04 Billion | 492.52 Million |
| Earnings Before Tax Margin | 0.08 | 0.09 | 0.10 | 0.09 | 0.08 | 0.08 |
NESN
RBSFY
MPP
PRICOLLTD
CFT
FOSUF